Global Patent Index - EP 1012172 A1

EP 1012172 A1 2000-06-28 - ACYLATED PEPTIDE CYTOLYTIC PEPTIDE INHIBITORS

Title (en)

ACYLATED PEPTIDE CYTOLYTIC PEPTIDE INHIBITORS

Title (de)

ACYLIERTE PEPTIDE ALS INHIBITOREN FÜR CYTOLYTISCHE PEPTIDE

Title (fr)

INHIBITEURS ACYLES DE PEPTIDES CYTOLYTIQUES

Publication

EP 1012172 A1 (EN)

Application

EP 97934376 A

Priority

  • AU 9700511 W
  • AU PO161196 A

Abstract (en)

[origin: WO9806743A1] The present invention relates to hybrid molecules and novel peptides which inhibit cytolytic compounds such as melittin. The invention also relates to pharmaceutical compositions including these inhibitors and to methods of inhibiting cytolytic compounds.

IPC 1-7 (main, further and additional classification)

C07K 7/06; A61K 38/04; C07K 5/065; C07K 5/068; C07K 5/08; C07K 5/087; C07K 5/097

IPC 8 full level (invention and additional information)

A61K 38/00 (2006.01); A61P 7/00 (2006.01); A61P 43/00 (2006.01); C07K 5/065 (2006.01); C07K 5/078 (2006.01); C07K 5/087 (2006.01); C07K 5/093 (2006.01); C07K 7/06 (2006.01)

CPC (invention and additional information)

C07K 7/06 (2013.01); C07K 5/0812 (2013.01); C07K 5/0819 (2013.01)

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

EPO simple patent family

WO 9806743 A1 19980219; AU PO161196 D0 19960905; CA 2263789 A1 19980219; EP 1012172 A1 20000628; EP 1012172 A4 20000628; JP 2001505541 A 20010424

INPADOC legal status


2001-10-17 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20010301

2000-11-08 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20000920

2000-06-28 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19990311

2000-06-28 [A4] SUPPLEMENTARY SEARCH REPORT

- Effective date: 20000222

2000-06-28 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

2000-06-28 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A4

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE